NEW YORK, July 24, 2023 /PRNewswire/ — Bernstein Liebhard LLP: Do you, or did you, own shares of ImmunityBio, Inc. (NASDAQ: IBRX)? Did you purchase your shares between May 23, 2022 and May 10, 2023, inclusive? Did you lose money in your investment in ImmunityBio, Inc.? Do you want to…